According to Santen Pharmaceutical 's latest financial reports the company's current EPS (TTM) is -$0.14. an increase over its 2021 EPS that were of $0.15.
Year | EPS | Change |
---|---|---|
2022 | $0.56 | 260.06% |
2021 | $0.15 | -71.71% |
2020 | $0.55 | -22.74% |
2019 | $0.71 | -13.12% |
2018 | $0.82 | 62.26% |
2017 | $0.50 | -56.2% |
2016 | $1.15 | 136.8% |
2015 | $0.48 | 20.31% |
2014 | $0.40 | -2.99% |
2013 | $0.42 | -12.62% |
2012 | $0.48 | -20.86% |
2011 | $0.60 | 27.6% |
2010 | $0.47 | 95.61% |
2009 | $0.24 | -17.8% |
2008 | $0.29 | 13.71% |
2007 | $0.26 | 0.88% |
2006 | $0.26 | 8.63% |
2005 | $0.23 |